KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.58 $2.88 Friday, 26th Apr 2024 PTN stock ended at $1.82. This is 5.81% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 8.93% from a day low at $1.68 to a day high of $1.83.
90 days $1.47 $5.65
52 weeks $1.43 $5.65

Historical Palatin Technologies Inc prices

Date Open High Low Close Volume
Mar 21, 2024 $1.58 $1.65 $1.55 $1.62 164 362
Mar 20, 2024 $1.60 $1.60 $1.47 $1.57 254 394
Mar 19, 2024 $1.58 $1.63 $1.53 $1.56 162 159
Mar 18, 2024 $1.55 $1.73 $1.52 $1.60 357 970
Mar 15, 2024 $1.54 $1.63 $1.51 $1.54 377 312
Mar 14, 2024 $1.60 $1.60 $1.50 $1.50 259 170
Mar 13, 2024 $1.70 $1.70 $1.60 $1.60 183 955
Mar 12, 2024 $1.75 $1.76 $1.64 $1.67 187 254
Mar 11, 2024 $1.88 $1.88 $1.63 $1.71 470 172
Mar 08, 2024 $1.93 $1.98 $1.79 $1.84 504 936
Mar 07, 2024 $1.88 $1.94 $1.83 $1.89 147 949
Mar 06, 2024 $1.98 $2.01 $1.83 $1.86 540 419
Mar 05, 2024 $1.98 $2.14 $1.96 $1.97 357 191
Mar 04, 2024 $2.24 $2.24 $1.95 $1.98 872 706
Mar 01, 2024 $2.04 $2.34 $2.02 $2.20 972 707
Feb 29, 2024 $2.29 $2.30 $1.86 $2.01 1 534 323
Feb 28, 2024 $2.20 $2.76 $2.04 $2.45 3 915 259
Feb 27, 2024 $3.65 $3.99 $3.56 $3.97 656 973
Feb 26, 2024 $3.11 $3.67 $3.02 $3.62 934 555
Feb 23, 2024 $3.12 $3.19 $2.96 $3.13 385 267
Feb 22, 2024 $3.21 $3.21 $2.97 $3.19 325 882
Feb 21, 2024 $3.21 $3.30 $2.86 $2.98 590 615
Feb 20, 2024 $3.09 $3.36 $3.00 $3.24 788 965
Feb 16, 2024 $3.26 $3.27 $2.96 $3.02 984 869
Feb 15, 2024 $4.03 $4.04 $3.05 $3.15 1 328 967
Click to get the best stock tips daily for free!

About Palatin Technologies Inc

Palatin Technologies Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatmen... PTN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT